Journal
JOURNAL OF IMMUNOLOGY
Volume 196, Issue 10, Pages 4040-4051Publisher
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1502276
Keywords
-
Categories
Funding
- National Center for Advancing Translational Science, National Institutes of Health (CTSA) [UL1 TR000142]
- National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health [P30KD034989]
- European Research Council under the European Union [640116]
- European Research Council (ERC) [640116] Funding Source: European Research Council (ERC)
Ask authors/readers for more resources
A subset of human regulatory T cells (Tregs) can secrete IFN-gamma or IL-17, and thus share features of T(H)1 or T(H)17 effector cells and lose suppressive function. The main factors driving this differentiation of Tregs toward a proinflammatory phenotype include IL-12 for T(H)1-like and IL-6 for T(H)17-type Tregs. In this study we show that Tregs of patients with de novo autoimmune hepatitis (dAIH) display increased frequencies of proinflammatory IFN-gamma and IL-17 cytokines. Irrespective of a fully demethylated FOXP3 locus, Tregs of subjects with dAIH are functionally impaired. In line with the observed Treg phenotype, we detected the presence of two dominant cytokines (IL-12 and IL-6) clustering with CD68(+) monocyte/macrophage cells in livers of subjects with dAIH, and isolated monocytes of subjects with dAIH secrete high levels of proinflammatory IL-12 and IL-6, suggesting that this inflammatory milieu is key for functional impairment of Tregs. Importantly, the blockade of IFN-gamma partially restores suppressive function of Tregs of subjects with dAIH, indicating that monocyte/macrophage-derived triggers might play a central role in Treg dysfunction and pathogenesis of dAIH.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available